Armed with what CEO Robert Davis called the “broadest and widest pipeline we’ve had in years,” Merck is preparing for its ...

If our underlying assumptions prove inaccurate or uncertainties materialize, actual results may differ materially from those ...

Palo Alto, Calif.-based Atropos Health, a company translating real-world clinical data into real-world evidence for decision-making, announced it is partnering with Merck to generate RWE, replicate ...

Eikon ‍Therapeutics (EIKN), a cancer drug developer led by Merck (MRK) veteran Roger Perlmutter, has filed for its U.S. IPO ...

FRANKFURT, Feb 18 (Reuters) - Germany's Merck KGaA (MRCG.DE), opens new tab said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but it ...

Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths ...

CEPI will provide Merck with $30 million and Merck will, in turn, leverage its joint venture with Wellcome, called Hilleman Laboratories, to develop an Ebola vaccine with an updated manufacturing ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive officer, and Dr. Dean Y. Li, ...

The firm missed Wall Street Q4 revenue estimates but assured steady growth as it plans for Keytruda's patent expirations, a ...